Ischemic-hemorrhagic stroke in patients with Covid-19

• Published in: Revista española de anestesiología y reanimación Vol. 67; no. 9; p. 516
• Main Authors: Azpiazu Landa, N, Velasco Oficialdegui, C, Intxaurraga Fernández, K, Gonzalez Larrabe, I, Riaño Onaindia, S, Telletxea Benguria, S
• Format: Journal Article
• Language: English
• Published: Spain 01.11.2020
• Subjects: Aged; Betacoronavirus; Coronavirus Infections - complications; COVID-19; Fatal Outcome; Hemorrhage - complications; Hemorrhage - diagnostic imaging; Humans; Ischemia - complications; Ischemia - diagnostic imaging; Male; Middle Aged; Pandemics; Pneumonia, Viral - complications; SARS-CoV-2; Stroke - diagnostic imaging; Stroke - etiology; Thrombotic Microangiopathies - complications; Thrombotic Microangiopathies - diagnostic imaging; Tomography, X-Ray Computed; Thrombotic microangiopathy; Stroke; Microangiopatía trombótica; Covid-19; Anticoagulation; Thrombosis; Anticoagulación; Neurology; SARS-CoV-2; Trombosis; Cardiovascular affectation; Accidente cerebrovascular; Afectación cardiovascular; Neurología
• ISSN: 2340-3284
• DOI: 10.1016/j.redar.2020.08.002

Coronavirus associated severe acute respiratory syndrome (SARS-CoV-2) causes a worldwide syndrome called Covid-19 that has caused 5,940,441 infections and 362,813 deaths until May 2020. In moderate and severe stages of the infection a generalized swelling, cytokine storm and an increment of the heart damage biomarkers occur. In addition, a relation between Covid-19 and neurological symptoms have been suggested. The results of autopsies suggest thrombotic microangiopathy in multiple organs. We present 2 cases of patients infected with severe Covid-19 that were hospitalized in the Reanimation Unit that presented cerebrovascular symptoms and died afterwards. A high dose prophylaxis with antithrombotic medication is recommended in patients affected by moderate to severe Covid-19.